Table of Content

1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.1.1. Rising Prevalence of Genetic Diseases and the Incorporation of Genomic Data in Clinical Workflows Driving Market Growth
4.2.1.2. Concerns Over the Security & Privacy of Genomic Data Limiting the Adoption of Genomics Products
4.2.1.3. Rising Adoption of Personalized Medicines and Gene Therapies
4.2.1.4. Commercializing and Scaling Genomic Technologies Remain Major Challenges for Market Stakeholders
4.2.2. Factor Analysis
4.3. Technology Trends
4.4. Genomics Market: Regulatory Analysis
4.4.1. North America
4.4.1.1. U.S.
4.4.1.2. Canada
4.4.2. Europe
4.4.2.1. Shift From Pre-Approval to A Lifecycle Approach
4.4.2.2. Classification Changes
4.4.2.3. Stronger Supervision
4.4.2.4. Clearer Rights and Responsibilities for Economic Operators
4.4.2.5. Traceability/EUDAMED
4.4.2.6. General Safety and Performance Requirements
4.4.2.7. Performance Evaluation and Clinical Evidence
4.4.3. Asia-Pacific
4.4.3.1. China
4.4.3.2. Japan
4.4.3.3. India
4.4.4. Latin America
4.4.5. Middle East & Africa
4.4.6. Guidelines and Regulations for Gene Therapy and Genome Editing
4.5. Pricing Analysis
4.6. Porter’s Five Forces Analysis
4.6.1. Bargaining Power of Buyers
4.6.2. Bargaining Power of Suppliers
4.6.3. Threat of Substitutes
4.6.4. Threat of New Entrants
4.6.5. Degree of Competition

5. Genomics Market Assessment?by Offering
5.1. Overview
5.2. Consumables
5.3. Instruments
5.4. Software
5.5. Services

6. Genomics Market Assessment?by Technology
6.1. Overview
6.2. Polymerase Chain Reaction (PCR)
6.3. Sequencing
6.3.1. Next-Generation Sequencing (NGS)
6.3.2. Other Sequencing Technologies
6.4. Nucleic Acid Extraction & Purification
6.5. Microarray
6.6. Other Technologies

7. Genomics Market Assessment?by Application
7.1. Overview
7.2. Diagnostics
7.3. Drug Discovery & Development
7.4. Life Sciences Research
7.4.1. Cancer Research
7.4.2. Stem Cell Research
7.4.3. Other Life Sciences Research
7.5. Other Applications

8. Genomics Market Assessment?by End User
8.1. Overview
8.2. Pharmaceutical & Biotechnology Companies
8.3. Hospitals & Clinics
8.4. Diagnostic Laboratories
8.5. Contract Research Organizations (CROs)
8.6. Academic & Research Institutes
8.7. Other End Users

9. Genomics Market Assessment?by Geography
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest Of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Rest Of Asia-Pacific
9.5. Latin America
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
9.6. Middle East & Africa

10. Competition Analysis
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
10.4.1. Industry Leaders
10.4.2. Market Differentiators
10.4.3. Vanguards
10.4.4. Emerging Companies
10.5. Market Share Analysis
10.5.1. Thermo Fisher Scientific Inc. (U.S.)
10.5.2. Illumina, Inc. (U.S.)
10.5.3. Qiagen N.V. (Netherlands)

11. Company Profiles (Company Overview, Financial Snapshot, Product Portfolio, and Strategic Developments)
11.1. Thermo Fisher Scientific Inc.
11.2. Illumina, Inc
11.3. Qiagen N.V.
11.4. Danaher Corporation
11.5. Agilent Technologies, Inc.
11.6. Bio-Rad Laboratories, Inc.
11.7. Pacific Biosciences of California, Inc.
11.8. Oxford Nanopore Technologies plc
11.9. Eppendorf SE
11.10. Myriad Genetics, Inc.
11.11. Reevity, Inc. (Formerly PerkinElmer, Inc.)
11.12. BGI Genomics Co.,Ltd.
(Note: SWOT Analysis of Top 5 Companies is Provided)

12. Appendix
12.1. Available Customization
12.2. Related Reports



List of Figures

Figure 1 Research Process
Figure 2 Secondary Sources Referred for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Dem and Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Genomics Market, by Offering, 2024 Vs. 2031 (USD Million)
Figure 8 Global Genomics Market, by Technology, 2024 Vs. 2031 (USD Million)
Figure 9 Global Genomics Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 10 Global Genomics Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 11 Genomics Market, by Geography
Figure 12 Impact Analysis of Market Dynamics
Figure 13 Healthcare Expenditure as A Percentage of GDP in Major Countries, 2015 Vs. 2020
Figure 14 Global Pharmaceutical R&D Expenditure, 2012–2022 (USD Billion)
Figure 15 Estimated Number of New Cancer Cases, by Region, 2020 Vs. 2030 (in Thousand)
Figure 16 Percentage of FDA Approvals for Personalized Medicine, 2015-2021
Figure 17 USFDA Regulatory Pathways for Genomic Products
Figure 18 EU Regulatory Pathway IVDR 2017/746
Figure 19 China: Medical Device Classification and Pre-Market Requirements for IVD Devices
Figure 20 Porter’s Five Forces Analysis
Figure 21 Global Genomics Market, by Offering, 2024 Vs. 2031 (USD Million)
Figure 22 Global Genomics Market, by Technology, 2024 Vs. 2031 (USD Million)
Figure 23 Global Genomics Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 24 Global Pharmaceutical R&D Expenditure, 2014?2026 (USD Billion)
Figure 25 Cancer Incidence Cases, 2020 Vs. 2040
Figure 26 Global Genomics Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 27 Global Pharmaceutical R&D Spending, 2012–2026 (USD Billion)
Figure 28 Global Genomics Market Assessment, by Region, 2024 Vs. 2031 (USD Million)
Figure 29 North America: Genomics Market Snapshot
Figure 30 Europe: Genomics Market Snapshot
Figure 31 Asia-Pacific: Genomics Market Snapshot
Figure 32 Latin America: Genomics Market Snapshot
Figure 33 Key Growth Strategies Adopted by Leading Players, 2020–2023
Figure 34 Genomics Market: Competitive Benchmarking, by Offering
Figure 35 Genomics Market: Competitive Benchmarking, by Geography
Figure 36 Competitive Dashboard: Genomics Market
Figure 37 Global Genomics Market Share Analysis, by Key Players
Figure 38 Thermo Fisher Scientific, Inc.: Financial Overview (2022)
Figure 39 Illumina, Inc.: Financial Overview (2022)
Figure 40 Qiagen N.V.: Financial Overview (2022)
Figure 41 Danaher Corporation: Financial Overview (2022)
Figure 42 Agilent Technologies, Inc.: Financial Overview (2023)
Figure 43 Bio-Rad Laboratories, Inc.: Financial Overview (2022)
Figure 44 Pacific Biosciences of California, Inc.: Financial Overview (2022)
Figure 45 Oxford Nanopore Technologies plc.: Financial Overview (2022)
Figure 46 Eppendorf SE: Financial Overview (2022)
Figure 47 Myriad Genetics, Inc.: Financial Overview (2022)
Figure 48 PerkinElmer, Inc.: Financial Overview (2022)
Figure 49 BGI Genomics Co.,Ltd.: Financial Overview (2022)